Jones Financial Companies Lllp Candel Therapeutics, Inc. Call Options Transaction History
Jones Financial Companies Lllp
- $298 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CADL
# of Institutions
87Shares Held
15.2MCall Options Held
536KPut Options Held
335K-
Baker Bros. Advisors LP New York, NY2.44MShares$13.1 Million0.16% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.15MShares$11.6 Million8.46% of portfolio
-
Northpond Ventures, LLC1.94MShares$10.4 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.74MShares$9.32 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA881KShares$4.73 Million0.41% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $155M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...